JPRN-UMIN000010451已完成未知
Clinical study on the effects of vildagliptin on glucose and lipid profiles in patients type 2 diabetes mellitus - Clinical study on the effects of vildagliptin on glucose and lipid profiles in patients type 2 diabetes mellitus
Department of Cardiology0 个研究点目标入组 100 人开始时间: 2013年4月11日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients with hypersensitivity to targeted medication 2)type 1 diabetes, diabetic ketoacidosis or diabetic coma 3)patients with severe liver dysfunaction 4)patients with severe infection or traumatic injury 5)pregnat, female with possiboility of pregnancy and breast-feeding 6)patients with severe complications 7)any other factors that may disqualify patients
研究者
相似试验
招募中
4 期
An study to assess the safety and efficacy of vildagliptin vs voglibose in management of post-prandial blood sugar in patients with T2DMCTRI/2024/08/072355Dr Mahima V
已完成
4 期
Comparison of utility of Viladagliptin 50 mg tablet twice daily and metformin combination therapy with Vildagliptin 100 mg sustained release tablet once daily and metformin combination therapy in Indian patients with type 2 diabetes mellitus: A randomized open label phase IV clinical trialCTRI/2021/10/037574Dr Rudra Paul
招募中
不适用
Comparison of efficacy and safety of Vildagliptin and Teneligliptin in patients with Type 2 Diabetes MellitusCTRI/2017/02/007766jawaharlal nehru medical college and hospital160
未知
3 期
To assess the efficacy and safety of vildagliptin as add-on therapy to sulfonylurea in patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapyType 2 DiabetesJPRN-jRCT2080220244ovartis Pharma K.K.200
未知
1 期
To Assess the Efficacy and Safety of Vildagliptin in Patients with Type 2 DiabetesType 2 DiabetesJPRN-jRCT2080220150ovartis Pharma K.K.264